Agency Information Collection Activities: Proposed Collection; Comment Request, 76625-76626 [2022-27233]
Download as PDF
Federal Register / Vol. 87, No. 240 / Thursday, December 15, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–2728]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 13, 2023.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number:ll,Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:51 Dec 14, 2022
Jkt 259001
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–2728 End Stage Renal Disease
Medical Evidence Report Medicare
Entitlement and/or Patient
Registration
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: End Stage Renal
Disease Medical Evidence Report
Medicare Entitlement and/or Patient
Registration; Use: Section 226A (2) of
the Social Security Act specifically
states that a person must be ‘‘medically
determined to have end stage renal
disease . . . .’’ Similarly, Section 188(a)
of the law states ‘‘The benefits provided
by parts A and B of this title shall
include benefits for individuals who
have been determined to have end stage
renal disease as provided in Section
226A’’. The End Stage Renal Disease
(ESRD) Medical Evidence (CMS–2728)
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
76625
is completed for all ESRD patients either
by the first treatment facility or by a
Medicare-approved ESRD facility when
it is determined by a physician that the
patient’s condition has reached that
stage of renal impairment that a regular
course of kidney dialysis or a kidney
transplant is necessary to maintain life.
The data reported on the CMS–2728
is used by the Federal Government,
ESRD Networks, treatment facilities,
researchers and others to monitor and
assess the quality and type of care
provided to end stage renal disease
beneficiaries. The data collection
captures the specific medical
information required to determine the
Medicare medical eligibility of End
Stage Renal Disease claimants. It also
collects data for research and policy on
this population.
The three main data systems available
for evaluating the ESRD program and for
monitoring epidemiology, access, and
quality and reimbursement effects on
quality are: (1) The United States Renal
Data System (USRDS) provides basic
data on patterns of incidence of ESRD
in the United States. The USRDS
database is intended to be used for
biomedical research by investigators
throughout the United States and
abroad. The USRDS data is intended to
supplement (and not replace) public use
files produced by CMS. (2) United
Network for Organ Sharing (UNOS)
focus is on organ donation,
transplantation and educational
activities. (3) The ESRD Program
Management and Medical System
(PMMIS), maintained by CMS, provide
the foundation data for the USRDS. This
system, as required by Public Law 95–
292, section C(1) (A), is designed to
serve the needs of the Department of
Health and Human Services in support
of program analysis, policy
development, and epidemiological
research.
The ESRD PMMIS includes
information on both Medicare and nonMedicare ESRD patients and on
Medicare approved ESRD hospitals and
dialysis facilities. The methods of ESRD
data collection (e.g., use of same forms,
sharing of analysis) by CMS, UNOS, and
USRDS have all agreed on a common
data collection process that will provide
needed additional information on the
ESRD population.
Due to response by the provider
community the CMS–2728 form has
been revised by adding questions,
clarifying questions, updating reasons
for kidney failure, updating
comorbidities to be more reflective of
pediatric patients, and providing
additional guidance and clarity in the
instructions. Form Number: CMS–2728
E:\FR\FM\15DEN1.SGM
15DEN1
76626
Federal Register / Vol. 87, No. 240 / Thursday, December 15, 2022 / Notices
(OMB control number: 0938–0046);
Frequency: Yearly; Affected Public:
Private Sector (Business or other forprofits, Not-for-Profit Institutions);
Number of Respondents: 7,828; Total
Annual Responses: 138,000; Total
Annual Hours: 138,000. (For policy
questions regarding this collection
contact Lisa Rees at (816) 426–6353).
Dated: December 12, 2022.
William N. Parham, III
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–27233 Filed 12–14–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10527, CMS–
10260, CMS–10836 and CMS–855A]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 13, 2023.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:51 Dec 14, 2022
Jkt 259001
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10527 Annual Eligibility
Redetermination, Product
Discontinuation and Renewal
Notice
CMS–10260 Medicare Advantage and
Prescription Drug Program: Final
Marketing Provisions in 42 CFR
422.111(a)(3) and 423.128(a)(3)
CMS–10836 Medicare Plan Performance
Warning Information
CMS–855A Medicare Enrollment
Application for Institutional
Providers
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Annual
Eligibility Redetermination, Product
Discontinuation and Renewal Notice;
Use: Section 1411(f)(1)(B) of the
Affordable Care Act directs the
Secretary of Health and Human Services
(the Secretary) to establish procedures
to redetermine the eligibility of
individuals for premium tax credits on
a periodic basis in appropriate
circumstances. Section 1321(a) of the
Affordable Care Act provides authority
for the Secretary to establish standards
and regulations to implement the
statutory requirements related to
Exchanges, qualified health plans
(QHPs) and other components of title I
of the Affordable Care Act. Under
section 2703 of the Public Health
Service Act (PHS Act), as added by the
Affordable Care Act, and former section
2712 and section 2741 of the PHS Act,
enacted by the Health Insurance
Portability and Accountability Act of
1996, health insurance issuers in the
group and individual markets must
guarantee the renewability of coverage
unless an exception applies.
The 2014 final rule ‘‘Patient
Protection and Affordable Care Act;
Annual Eligibility Redeterminations for
Exchange Participation and Insurance
Affordability Programs; Health
Insurance Issuer Standards Under the
Affordable Care Act, Including
Standards Related to Exchanges’’ (79 FR
52994, September 5, 2014), provides
that an Exchange may choose to conduct
the annual redetermination process for
a plan year (1) in accordance with the
existing procedures described in 45 CFR
155.335; (2) in accordance with
procedures described in guidance
issued by the Secretary for the
applicable benefit year; or (3) using an
alternative procedure proposed by the
Exchange and approved by the
Secretary. The 2014 final rule
established a renewal and reenrollment
hierarchy at 45 CFR 155.335(j) to
minimize potential enrollment
disruptions. The 2016 final rule ‘‘Patient
Protection and Affordable Care Act;
HHS Notice of Benefit and Payment
Parameters for 2017’’ (81 FR 12204,
March 8, 2016) amended the enrollment
E:\FR\FM\15DEN1.SGM
15DEN1
Agencies
[Federal Register Volume 87, Number 240 (Thursday, December 15, 2022)]
[Notices]
[Pages 76625-76626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27233]
[[Page 76625]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-2728]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and clarity of the information to be collected, and
the use of automated collection techniques or other forms of
information technology to minimize the information collection burden.
DATES: Comments must be received by February 13, 2023.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number:__,Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-2728 End Stage Renal Disease Medical Evidence Report Medicare
Entitlement and/or Patient Registration
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Reinstatement with
change of a previously approved collection; Title of Information
Collection: End Stage Renal Disease Medical Evidence Report Medicare
Entitlement and/or Patient Registration; Use: Section 226A (2) of the
Social Security Act specifically states that a person must be
``medically determined to have end stage renal disease . . . .''
Similarly, Section 188(a) of the law states ``The benefits provided by
parts A and B of this title shall include benefits for individuals who
have been determined to have end stage renal disease as provided in
Section 226A''. The End Stage Renal Disease (ESRD) Medical Evidence
(CMS-2728) is completed for all ESRD patients either by the first
treatment facility or by a Medicare-approved ESRD facility when it is
determined by a physician that the patient's condition has reached that
stage of renal impairment that a regular course of kidney dialysis or a
kidney transplant is necessary to maintain life.
The data reported on the CMS-2728 is used by the Federal
Government, ESRD Networks, treatment facilities, researchers and others
to monitor and assess the quality and type of care provided to end
stage renal disease beneficiaries. The data collection captures the
specific medical information required to determine the Medicare medical
eligibility of End Stage Renal Disease claimants. It also collects data
for research and policy on this population.
The three main data systems available for evaluating the ESRD
program and for monitoring epidemiology, access, and quality and
reimbursement effects on quality are: (1) The United States Renal Data
System (USRDS) provides basic data on patterns of incidence of ESRD in
the United States. The USRDS database is intended to be used for
biomedical research by investigators throughout the United States and
abroad. The USRDS data is intended to supplement (and not replace)
public use files produced by CMS. (2) United Network for Organ Sharing
(UNOS) focus is on organ donation, transplantation and educational
activities. (3) The ESRD Program Management and Medical System (PMMIS),
maintained by CMS, provide the foundation data for the USRDS. This
system, as required by Public Law 95-292, section C(1) (A), is designed
to serve the needs of the Department of Health and Human Services in
support of program analysis, policy development, and epidemiological
research.
The ESRD PMMIS includes information on both Medicare and non-
Medicare ESRD patients and on Medicare approved ESRD hospitals and
dialysis facilities. The methods of ESRD data collection (e.g., use of
same forms, sharing of analysis) by CMS, UNOS, and USRDS have all
agreed on a common data collection process that will provide needed
additional information on the ESRD population.
Due to response by the provider community the CMS-2728 form has
been revised by adding questions, clarifying questions, updating
reasons for kidney failure, updating comorbidities to be more
reflective of pediatric patients, and providing additional guidance and
clarity in the instructions. Form Number: CMS-2728
[[Page 76626]]
(OMB control number: 0938-0046); Frequency: Yearly; Affected Public:
Private Sector (Business or other for-profits, Not-for-Profit
Institutions); Number of Respondents: 7,828; Total Annual Responses:
138,000; Total Annual Hours: 138,000. (For policy questions regarding
this collection contact Lisa Rees at (816) 426-6353).
Dated: December 12, 2022.
William N. Parham, III
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2022-27233 Filed 12-14-22; 8:45 am]
BILLING CODE 4120-01-P